Terumo introduces cell & gene therapy ecosystem blueprint for APAC

March 6, 2026 | Friday | News

A collaborative integration model to enable practical, scalable cell and gene therapy delivery

image credit- shutterstock

image credit- shutterstock

Terumo Blood and Cell Technologies (Terumo BCT) has announced the launch of its new cell & gene therapy (C&GT) Ecosystem Blueprint — a practical, collaborative approach designed to help cell and gene therapy developers in the Asia-Pacific (APAC) region move from early development to scalable, repeatable delivery.

C&GT activity is accelerating across APAC, but many programmes face persistent challenges in translating scientific progress into consistent, scalable operations. These challenges include fragmented workflows, high operating costs, shortages of GMP-trained talent and variation in regulatory and manufacturing readiness among markets.

Rather than focusing on individual technologies or isolated process steps, the C&GT Ecosystem Blueprint provides a clear map of how critical capabilities, workflows and partnerships must come together — from cell collection and processing through clinical readiness — to simplify complex workflows and support more cost-efficient, scalable C&GT development and manufacturing.

Terumo BCT will be applying the blueprint in collaboration with regional partners and C&GT developers across multiple real-world use cases, including the CiRA Foundation to co-develop standardized induced pluripotent stem cell (iPSC) workflows; GenScript contributing upstream cell selection and activation technologies and EurekaBio integrating downstream processing — together enabling an integrated, end-to-end CAR-T workflow solution; and KBIOHealth and Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) to address regional GMP training and implementation capabilities.

 

Terumo BCT designed its C&GT Ecosystem Blueprint around three core pillars: Fit-for-purpose workflows adaptable to different C&GT modalities and development stages; integrated capability and capacities that enable simplified GMP-compliant workflows, reduced variability and operational cost as programs scale; and collaborative execution models that align developers, technology providers and regional partners around shared readiness goals.

Sign up for the editor pick and get articles like this delivered right to your inbox.

+Country Code-Phone Number(xxx-xxxxxxx)

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account